Albertsons Q4 underscores pharmacy pressure

Albertsons’ Q4 results showed continued pressure on its pharmacy, with a $773.8 million opioid-related charge causing a net loss and highlighting reimbursement and pricing issues.https://chaindrugreview.com/albertsons-q4-underscores-pharmacy-pressure/